Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli-Reference-Cited by-同舟云学术

Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli

Published:2016-06-02 Issue:6 Volume:11 Page:e0156692
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Einsfeldt Karen,Baptista Isis Cavalcante,Pereira Juliana Christina Castanheira Vicente,Costa-Amaral Isabele Campos,Costa Elaine Sobral da,Ribeiro Maria Cecília Menks,Land Marcelo Gerardin Poirot,Alves Tito Lívio Moitinho,Larentis Ariane Leites,Almeida Rodrigo Volcan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia;UK Narta;Crit Rev Oncol Hematol,2007

2. L-asparaginase: a promising chemotherapeutic agent;N Verma;Crit Rev Biotechnol,2007

3. L-asparaginase from Erwinia carotovora. An improved recovery and purification process using affinity chromatography;SM Lee;Appl Biochem Biotechnol,1989

4. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children’s Leukemia Group phase 3 trial;M Duval;Blood,2002

5. L-asparaginase from Erwinia Chrysanthemi 3937: Cloning, expression and characterization;GA Kotzia;J Biotechnol,2007

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of structural behaviour of a new L-asparaginase and SAXS data-based evidence for catalytic activity in its monomeric form;International Journal of Biological Macromolecules;2023-12

2. Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production;International Journal of Molecular Sciences;2023-10-16

3. Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems;Frontiers in Pharmacology;2023-06-22

4. Biochemical characterization of extremozyme L-asparaginase from Pseudomonas sp. PCH199 for therapeutics;AMB Express;2023-02-24

5. Assessment of structural behaviour of new L-asparaginase and SAXS data-based evidence for catalytic activity in its monomeric form;2023-01-02